BISACODYL
-
bisacodyl tablet
Cardinal Health
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.
Relieves occasional constipation and irregularity. This product generally produces bowel movement in 6 to 12 hours
This package is intended for institutional use only. If pregnant or breast-feeding, ask a doctor before use.
Do not use if you cannot swallow without chewing
Ask a doctor before use if you have stomach pain, nausea or vomiting or a sudden change in bowel habits that lasts over 2 weeks.
When using this product do not chew or crush tablet, do not use within 1 hour after taking an antacid or milk. When using this product you may have stomach discomfort, faintness or cramps.
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use. These may be signs of a serious condition. Stop use and ask a doctor if you need to use a laxative for more than 1 week.
adults and children 12 years and over | take 1 to 3 tablets (usually 2) in a single daily dose |
children 6 to under 12 years | take 1 tablet daily |
children under 6 years | ask a doctor |
Acacia, bees wax, calcium sulfate, carnauba wax, cellulose, corn starch, D&C yellow #10 lake, FD&C yellow #6 lake, gelatin, lactose, magnesium stearate, pharmaceutical glaze, polyvinyl acetate phthalate, silica gel, sodium starch glycolate, stearic acid, sugar, talc, titanium dioxide
Store at to 20-25 C (68 to 77 F); excursions permitted to 15-30 C (59-86 F). [See USP Controlled Room Temperature].
Avoid excessive humidity.
Adverse Drug Even Call: (800) 616-2471
Distributed by
MAJOR PHARMACEUTICALS
31778 Enterprise Drive
Livonia, MI 48150 USA
MFGD By LNK, Hauppauge, NY11788
Repackaged by Cardinal Health
Zanesville, OH 43701
BISACODYL
bisacodyl tablet |
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
Unapproved drug other | 06/02/2011 |
Labeler - Cardinal Health (188557102) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Cardinal Health | 188557102 | REPACK |
Revised: 07/2011 Cardinal Health